tiprankstipranks

Longeveron appoints Agafonova as CMO

Longeveron (LGVN) announced the appointment of Nataliya Agafonova, M. D., as the Company’s Chief Medical Officer, CMO, effective as of July 1, 2023. As CMO, Dr. Agafonova will lead Longeveron’s global clinical development and regulatory strategy for the Company’s investigational products. Dr. Agafonova joins Longeveron from Otsuka Pharmaceutical (OTSKY), where she served as Clinical Development Lead, Senior Medical Director, and Product Development Chair.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on LGVN:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue